Your browser doesn't support javascript.
loading
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Magnaghi, Paola; Salom, Barbara; Cozzi, Liviana; Amboldi, Nadia; Ballinari, Dario; Tamborini, Elena; Gasparri, Fabio; Montagnoli, Alessia; Raddrizzani, Laura; Somaschini, Alessio; Bosotti, Roberta; Orrenius, Christian; Bozzi, Fabio; Pilotti, Silvana; Galvani, Arturo; Sommer, Josh; Stacchiotti, Silvia; Isacchi, Antonella.
Afiliación
  • Magnaghi P; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy. paola.magnaghi@nervianoms.com.
  • Salom B; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Cozzi L; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Amboldi N; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Ballinari D; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Tamborini E; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gasparri F; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Montagnoli A; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Raddrizzani L; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Somaschini A; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Bosotti R; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Orrenius C; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Bozzi F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pilotti S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Galvani A; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
  • Sommer J; Chordoma Foundation, Durham, North Carolina.
  • Stacchiotti S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Isacchi A; Oncology, Nerviano Medical Sciences, Nerviano, Milan, Italy.
Mol Cancer Ther ; 17(3): 603-613, 2018 03.
Article en En | MEDLINE | ID: mdl-29237806

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Cordoma / Proteínas de Dominio T Box / Ensayos Antitumor por Modelo de Xenoinjerto / Proteínas Fetales / Receptores ErbB / Afatinib Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Cordoma / Proteínas de Dominio T Box / Ensayos Antitumor por Modelo de Xenoinjerto / Proteínas Fetales / Receptores ErbB / Afatinib Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2018 Tipo del documento: Article País de afiliación: Italia